CN105928771B - 一种检测疫苗抗原含量的样品前处理方法 - Google Patents
一种检测疫苗抗原含量的样品前处理方法 Download PDFInfo
- Publication number
- CN105928771B CN105928771B CN201610260663.6A CN201610260663A CN105928771B CN 105928771 B CN105928771 B CN 105928771B CN 201610260663 A CN201610260663 A CN 201610260663A CN 105928771 B CN105928771 B CN 105928771B
- Authority
- CN
- China
- Prior art keywords
- sample
- vaccine
- ultrapure water
- added
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 73
- 229960005486 vaccine Drugs 0.000 title claims abstract description 62
- 239000000427 antigen Substances 0.000 title claims abstract description 57
- 102000036639 antigens Human genes 0.000 title claims abstract description 57
- 108091007433 antigens Proteins 0.000 title claims abstract description 57
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 51
- 239000012498 ultrapure water Substances 0.000 claims abstract description 51
- 230000000890 antigenic effect Effects 0.000 claims abstract description 33
- 238000001514 detection method Methods 0.000 claims abstract description 33
- 239000006228 supernatant Substances 0.000 claims abstract description 21
- 239000002244 precipitate Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 28
- 239000013558 reference substance Substances 0.000 claims description 21
- 238000005119 centrifugation Methods 0.000 claims description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 229960002766 tetanus vaccines Drugs 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 15
- 238000003908 quality control method Methods 0.000 claims description 14
- 239000012085 test solution Substances 0.000 claims description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 8
- 229940098773 bovine serum albumin Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 230000001376 precipitating effect Effects 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 6
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000002798 spectrophotometry method Methods 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 5
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000011084 recovery Methods 0.000 abstract description 34
- 238000002203 pretreatment Methods 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 238000011017 operating method Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 238000005215 recombination Methods 0.000 description 13
- 230000006798 recombination Effects 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000011534 incubation Methods 0.000 description 8
- 238000012417 linear regression Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000001472 potassium tartrate Substances 0.000 description 4
- 229940111695 potassium tartrate Drugs 0.000 description 4
- 235000011005 potassium tartrates Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010055044 Tetanus Toxin Proteins 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229940031626 subunit vaccine Drugs 0.000 description 3
- 229940118376 tetanus toxin Drugs 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 235000019624 protein content Nutrition 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016102175599 | 2016-04-08 | ||
CN201610217559 | 2016-04-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105928771A CN105928771A (zh) | 2016-09-07 |
CN105928771B true CN105928771B (zh) | 2019-01-18 |
Family
ID=56836134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610260663.6A Expired - Fee Related CN105928771B (zh) | 2016-04-08 | 2016-04-25 | 一种检测疫苗抗原含量的样品前处理方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105928771B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106520870B (zh) * | 2016-12-29 | 2019-12-13 | 四川自豪时代药业有限公司 | 外源表达破伤风毒素受体结合区Hc的高密度发酵方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2770001A (en) * | 2000-01-07 | 2001-07-24 | Aventis Pasteur | Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigens |
EP1714981A3 (en) * | 2002-10-02 | 2006-12-20 | F.Hoffmann-La Roche Ag | Method for the identification of antigenic peptides |
JP2012239438A (ja) * | 2011-05-21 | 2012-12-10 | Micro Blood Science Co Ltd | バルトネラ・ヘンセラエ抗原の調製方法、および該方法により得られるバルトネラ・ヘンセラエ調製抗原 |
-
2016
- 2016-04-25 CN CN201610260663.6A patent/CN105928771B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN105928771A (zh) | 2016-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104034893B (zh) | 一种基于胶乳的三聚氰胺快速检测方法及试剂盒 | |
CN108490177A (zh) | 鼻咽癌抗体检测试剂、其制备方法及鼻咽癌检测试剂盒 | |
CN105745541B (zh) | 流感病毒免疫测定中的检样处理方法和免疫测定方法 | |
US20230193194A1 (en) | Generic inert bio-vector salmonella sp. and potential uses thereof | |
CN111848750B (zh) | 一种快速富集和检测2019-nCoV的方法及试剂盒 | |
CN105928771B (zh) | 一种检测疫苗抗原含量的样品前处理方法 | |
CN106501511A (zh) | 一种重组Neu蛋白检测副猪嗜血杆菌抗体的间接ELISA方法及其试剂盒 | |
CN109470849A (zh) | 一种副猪嗜血杆菌抗体检测试剂盒及其使用方法 | |
CN106518989B (zh) | 用于检测猪Delta冠状病毒抗体的多肽、制备方法及其应用 | |
CN108918869B (zh) | fiber2蛋白及其重组蛋白在检测血清4型禽腺病毒抗体方面的应用 | |
CN107586885A (zh) | 一种用于扩增甲型流感病毒的lamp引物组及试剂盒 | |
CN109239341A (zh) | 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用 | |
CN112175072B (zh) | 抗h5亚型禽流感病毒血凝素蛋白单克隆抗体zju5-01及其应用 | |
CN107219365A (zh) | 一种基于口蹄疫病毒3b表位蛋白的化学发光检测试剂盒 | |
CN106596934B (zh) | 一种检测o型口蹄疫病毒的试剂盒 | |
CN110095607A (zh) | 用于检测1型和3型鸭甲型肝炎病毒血清抗体的通用型间接elisa试剂盒及其应用 | |
CN108956986B (zh) | 新城疫病毒抗体检测试剂盒 | |
CN108061800A (zh) | 猪瘟抗体胶体金检测卡及其制备方法 | |
CN105277713B (zh) | 基于磁性分离和量子点标记的人肺炎链球菌快速检测方法和试剂盒 | |
CN104297309B (zh) | 检测致病菌的电化学传感器、制备方法及其应用 | |
CN108303533A (zh) | 一种脊髓灰质炎病毒ⅰ型d抗原预包被检测方法及其检测试剂盒和应用 | |
CN110196325A (zh) | 塞内卡病毒病诊断试剂盒及试纸 | |
CN107064501A (zh) | 一种定量检测猪瘟病毒IgG抗体竞争ELISA试剂盒及其检测方法 | |
CN108196049A (zh) | 一种禽白血病病毒的化学发光抗原定量检测试剂盒及其检测方法 | |
CN114014934B (zh) | 多氯联苯单克隆抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181017 Address after: 850000 Room 501, unit 2, 1 B, sunshine District, Tibet economic and Technological Development Zone, Lhasa Applicant after: Tibet everlasting Investment Co.,Ltd. Address before: 610000 Sichuan province Meishan Economic Development Zone, western new drug Valley No. 9 road. Applicant before: SICHUAN ZIHAOSHIDAI PHARMACEUTICAL CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201012 Address after: 518000 Shenkan building 2111-2112, No. 1043 shangbuzhong Road, Fuqiang community, Huaqiang North Street, Futian District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Changzhi Information Consulting Co.,Ltd. Address before: 850000 Room 501, unit 2, 1 B, sunshine District, Tibet economic and Technological Development Zone, Lhasa Patentee before: Tibet everlasting Investment Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 2001-2002 Shenkan building, 1043 Shangbu Middle Road, Fuqiang community, Huaqiangbei street, Futian District, Shenzhen, Guangdong 518000 Patentee after: Shenzhen changchangzhi Pharmaceutical Co.,Ltd. Address before: 518000 Shenkan building 2111-2112, No. 1043 shangbuzhong Road, Fuqiang community, Huaqiang North Street, Futian District, Shenzhen City, Guangdong Province Patentee before: Shenzhen Changzhi Information Consulting Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190118 |
|
CF01 | Termination of patent right due to non-payment of annual fee |